Genfit
GNFT · Euronext Paris
Public Market Listing
Live quotes, historical charts, and market capitalization for Genfit are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
| Target & Modality | |||
|---|---|---|---|
Elafibranor(Iqirvo) | Approved | PPAR-alpha/PPAR-deltaSmall molecule | Cholestatic Liver Disease Primary Biliary Cholangitis |
| Phase 1/2 | PPT1 (palmitoyl-protein thioesterase 1)Small molecule | Biliary Tract Cancer Cholangiocarcinoma with KRAS Mutation |
Upcoming events
(5 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (1)
December 2026 (1)
What to watch
2027 (1)
December 2027 (1)
What to watch
2029 (1)
May 2029 (1)
What to watch
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent